Vimarsana
Biggest News Aggregation in the World

Orthopedic Physicians News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Orthopedic Physicians. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Orthopedic Physicians Today - Breaking & Trending Today

Mass General orthopedic physicians return to 2 Steward hospitals - Vimarsana News

Mass General orthopedic physicians return to 2 Steward hospitals

Orthopedic physicians who were working at Mass General Brigham in Boston are returning to Holy Family hospitals in Haverhill and Methuen, Mass., Boston Business

Meet the physicians who provide care for the 11 highest-paid NBA players - Vimarsana News

Meet the physicians who provide care for the 11 highest-paid NBA players

LeBron James has been named the highest paid NBA player of 2023 with a $117.6 million contract, according to Forbes. 11 highest-paid players are listed, along

10 spine and orthopedic surgeons to know - Vimarsana News

10 spine and orthopedic surgeons to know

This article features 10 spine and orthopedic surgeons who have had a positive impact on their organizations and the specialty.

Horizon Therapeutics plc: Sustained Patient Response to KRYSTEXXA (pegloticase) Injection with Methotrexate Compared to KRYSTEXXA Alone Shown through Month 12 in MIRROR Randomized Controlled Trial - Vimarsana News

Horizon Therapeutics plc: Sustained Patient Response to KRYSTEXXA (pegloticase) Injection with Methotrexate Compared to KRYSTEXXA Alone Shown through Month 12 in MIRROR Randomized Controlled Trial

-- Month 12 results from MIRROR randomized controlled trial to be featured on Nov. 13, 11:45 a.m. EST during plenary session at the American College of Rheumatology Convergence 2022 -- -- Imaging

Horizon Therapeutics plc: FDA Approves KRYSTEXXA (pegloticase) Injection Co-Administered With Methotrexate, Expanding the Labeling to Help More People with Uncontrolled Gout Achieve a Complete Response to Therapy - Vimarsana News

Horizon Therapeutics plc: FDA Approves KRYSTEXXA (pegloticase) Injection Co-Administered With Methotrexate, Expanding the Labeling to Help More People with Uncontrolled Gout Achieve a Complete Response to Therapy

-- Approval based on MIRROR randomized controlled trial, which showed significant improvement and sustained patient response to KRYSTEXXA with methotrexate compared to KRYSTEXXA alone -- -- Trial